Study of Retinal Vascular Changes After Ocular Blunt Trauma
NCT ID: NCT04546997
Last Updated: 2020-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2019-01-10
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OCTA and Retinal Angiomatous Proliferation
NCT04689789
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
NCT05644548
Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion
NCT04075695
Optical Coherence Tomography Angiography and Choroidal Osteoma
NCT05342324
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NCT04505618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed analysis of retinal vascular features.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with ocular blunt trauma
Patients with previous ocular blunt trauma in one eye.
Optical Coherence Tomography Angiography
Patients underwent non-invasive, fast, diagnostic imaging technique (optical coherence tomography angiography)
Control Group
Healthy fellow eyes without actual and previous ocular trauma
Optical Coherence Tomography Angiography
Patients underwent non-invasive, fast, diagnostic imaging technique (optical coherence tomography angiography)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical Coherence Tomography Angiography
Patients underwent non-invasive, fast, diagnostic imaging technique (optical coherence tomography angiography)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of previous ocular blunt trauma
* absence of previous ocular surgery, congenital eye disease, high myopia (\>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
* absence of significant lens opacities, low-quality OCT and OCT-A images.
Exclusion Criteria
* absence of previous ocular blunt trauma
* presence of previous ocular surgery, congenital eye disease, high myopia (\>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
* presence of significant lens opacities, low-quality OCT and OCT-A images.
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gilda Cennamo
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilda Cennamo, MD
Role: PRINCIPAL_INVESTIGATOR
Federico II University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Naples "Federico II"
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1212/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.